ClinicalTrials.Veeva

Menu

Cognitive Behavioral Therapy (CBT) Study Evaluating the Updating of Persecutory Beliefs

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Completed

Conditions

Schizophrenia; Psychosis
Persecutory Delusion

Treatments

Behavioral: Worry Intervention
Behavioral: Befriending

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to examine how Bayesian belief updating changes throughout psychotherapeutic treatment for persecutory delusions. Specifically, individuals with a psychotic disorder diagnosis who endorse both a current persecutory delusion with strong conviction and significant worry will be recruited and randomized to receive either a CBT-based worry intervention for persecutory delusions or an active control condition (befriending therapy). The investigators will examine: 1) whether belief updating parameters change as delusion severity changes, 2) whether CBT contributes to greater change in belief updating parameters than befriending therapy, and 3) whether neural correlates of belief updating parameters, as measured using functional magnetic resonance imaging (fMRI), predict treatment response.

Enrollment

62 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Men and women age 18 - 65.
  2. Communicative in English.
  3. Premorbid Intelligence >79 (WTAR)
  4. Provide voluntary, written informed consent.
  5. Physically healthy by medical history.
  6. Weight <300 lbs
  7. Stable medication regimen over at least the past two weeks, including the use of either an oral or intramuscular administration of an antipsychotic medication.
  8. Diagnosis of a non-affective psychotic disorder (schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, brief psychotic disorder, psychosis NOS) confirmed by Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-5 (SCID) or diagnostic interview with a trained clinician.
  9. A persecutory delusion scoring at least a 3 on the conviction scale of the Psychotic Symptoms Rating Scale (PSYRATS) that had persisted for at least two weeks and that was not considered the direct result of substance use
  10. A clinically significant level of worry, as shown by a score of at least 44 on the Penn State Worry Questionnaire (PSWQ).

Exclusion criteria

  1. Age less than 18 or greater than 65.
  2. Not communicative in English.
  3. Premorbid IQ < 79 (WTAR)
  4. Unable to provide written informed consent.
  5. Current medical or neurological illness.
  6. History of severe head trauma.
  7. Weight >300 lbs
  8. Primary diagnosis of alcohol or substance use disorder or personality disorder
  9. Conditions that preclude fMRI scanning (as defined in the fMRI Screening Form)
  10. Subjects who are actively involved with individual cognitive therapy (Past experience with individual therapy is not an exclusion)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

62 participants in 2 patient groups

Worry Intervention
Experimental group
Description:
The Worry Intervention uses cognitive-behavioral therapy (CBT) techniques to support the patient in reducing the amount of time they worry throughout the week. It is an 8-week manualized treatment with 5 modules. Each session is 45-60 minutes.
Treatment:
Behavioral: Worry Intervention
Befriending
Active Comparator group
Description:
Befriending therapy controls for the general factors of therapy (warmth, engagement) without any 'active' interventions. Individuals in the befriending arm will spend sessions talking with the therapist about things that interest them. It will also be conducted over 8-weeks with 45-60 minute sessions.
Treatment:
Behavioral: Befriending

Trial contacts and locations

1

Loading...

Central trial contact

Julia M Sheffield, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems